What cerebrospinal fluid tests are recommended to diagnose neurosyphilis?

CSF Tests for Neurosyphilis

The diagnosis of neurosyphilis requires a combination of CSF tests including VDRL-CSF (the standard serologic test), CSF white blood cell count (>5 WBCs/mm³), and CSF protein, as no single test can diagnose neurosyphilis alone 1.

Core Diagnostic Algorithm

Essential CSF Tests

1. VDRL-CSF (Standard Serologic Test)

   • Highly specific but insensitive (sensitivity 49-87.5%, specificity 74-100%) 2
   • When reactive in the absence of substantial blood contamination, it is considered diagnostic of neurosyphilis 1
   • Critical caveat: VDRL-CSF may be nonreactive even when neurosyphilis is present 1
   • Note: RPR is NOT performed on CSF; only VDRL is the standard 3

2. CSF White Blood Cell Count

   • Usually elevated >5 WBCs/mm³ in neurosyphilis 1
   • Most sensitive measure of treatment effectiveness 1
   • Should normalize within 6 months of appropriate therapy 1

3. CSF Protein

   • Typically elevated when neurosyphilis is present
   • Changes more slowly than cell counts after treatment 4

Optional Adjunctive Test

FTA-ABS on CSF (Treponemal Test)

• Less specific than VDRL-CSF (yields more false-positives) 1
• Highly sensitive - some specialists believe a negative CSF FTA-ABS excludes neurosyphilis 1
• Use when VDRL-CSF is negative but clinical suspicion remains high

Diagnostic Interpretation Framework

Neurosyphilis diagnosis depends on combinations of:

• Reactive serologic test results (serum)
• CSF abnormalities (elevated WBC count or protein)
• Reactive VDRL-CSF
• Clinical manifestations (with or without symptoms) 1

Important Clinical Pitfalls

Blood Contamination

• Substantial CSF blood contamination can cause false-positive VDRL-CSF, particularly in patients with high serum VDRL titers 1, 2
• Two case reports document false-positive CSF VDRL with CNS malignancy 2

HIV-Infected Patients

• Serologic tests remain accurate and reliable for most HIV-infected patients 1
• Atypical results (unusually high, low, or fluctuating titers) can occur 1
• Highest neurosyphilis risk with serum RPR >1:32 2

Special Populations Requiring CSF Examination

Mandatory CSF examination when:

• Clinical evidence of neurologic involvement (cognitive dysfunction, motor/sensory deficits, cranial nerve palsies, meningitis symptoms) 1, 4
• Syphilitic uveitis or ocular manifestations - frequently associated with neurosyphilis 1, 4
• Otic symptoms with syphilis (though up to 90% may have normal CSF) 5

Note on ocular syphilis: Recent guidance suggests CSF examination may not be necessary in patients with isolated ocular symptoms, reactive serology, and confirmed ocular abnormalities on examination, as nearly 40% have no CSF abnormalities 5. However, these patients should still be treated as neurosyphilis.

Alternative Nontreponemal Tests

Recent research shows CSF-RPR and CSF-TRUST may serve as alternatives to VDRL-CSF with comparable performance:

• CSF-RPR: sensitivity 51.5-81.8%, specificity 81.8-100% 2
• High inter-rater reliability between VDRL, RPR, and USR tests 6, 7
• However, titers from different tests cannot be compared directly 1

Monitoring Treatment Response

• Repeat CSF examination every 6 months if initial pleocytosis was present, until cell count normalizes 1, 4
• CSF leukocyte count is the most sensitive measure of treatment effectiveness 1
• If cell count hasn't decreased after 6 months or CSF not normal after 2 years, consider retreatment 4
• Important: Normalization of serum RPR titer predicts normalization of CSF parameters in immunocompetent persons and HIV-infected persons on effective antiretroviral therapy, potentially eliminating need for repeated lumbar punctures 4, 5